Origen de la red de primer grado Geoff Shapiro.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom.
19
| Holding Company | Pharmaceuticals: Major | 19 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Geoff Shapiro a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
POXEL | Pharmaceuticals: Major | Chairman Director/Board Member | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Chairman Director of Finance/CFO | |
Upstream Bio, Inc.
Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
University College London | College/University | Doctorate Degree Doctorate Degree | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor Private Equity Investor | |
Faculty of Pharmaceutical Medicine | Director/Board Member | ||
Janssen-Cilag Ltd.
Janssen-Cilag Ltd. Pharmaceuticals: MajorHealth Technology Janssen-Cilag Ltd. provides pharmaceutical products and services. It offers medicines that can treat serious health conditions such as schizophrenia, epilepsy, multiple myeloma, and human immunodeficiency virus/acquired immunodeficiency syndrome. The firm's other key areas of activity include pain management, gastroenterology, fungal infections, women’s health, neurology, and anaemia. The company was founded on October 19, 1971 and is headquartered in High Wycombe, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Founder | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Royal College of Physicians | College/University | Corporate Officer/Principal | |
TopiVert Ltd.
TopiVert Ltd. BiotechnologyHealth Technology TopiVert Ltd. develops topical treatments for inflammatory diseases of the eye and gut. Its application is used in the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis and other inflammatory diseases of the lungs. The company was founded by Eric Charles Meldrum in 2011 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer | |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Founder | |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
PricewaterhouseCoopers LLP (United Kingdom)
PricewaterhouseCoopers LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLP engages in the provision of accounting services. Its services include audit and assurance, accounting advisory, risk assurance, tax management, corporate insolvency, life cycle assessment, forensic services, private equity advisory, and financial reporting valuations. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
China Kanghui Holdings
China Kanghui Holdings Medical SpecialtiesHealth Technology China Kanghui Holdings operates as a holding company that develops, manufactures and markets orthopedic implants. The company was founded by Yi Kang Jiang on April 19, 2006 and is headquartered in Changzhou, China. | Medical Specialties | Corporate Officer/Principal | |
SAGENT PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
aQuantive, Inc.
aQuantive, Inc. Advertising/Marketing ServicesCommercial Services aQuantive, Inc. designs and develops digital marketing services and provides related online solutions. The company offers services such as online media buying and planning, ad campaign management, e-mail direct marketing, search engine optimization, and data warehousing and analysis. The company was founded in 1997 and is headquartered in Seattle, WA | Advertising/Marketing Services | Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
Synaptic Medical International | Director/Board Member | ||
KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
Outpost Medicine, Inc.
Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Outpost Medicine LLC develops therapeutics for the treatment of urologic and gynecologic disorders. The company was founded by David Socks and Tachi Yamada in 2016 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member | |
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Trinity Biosystems, Inc.
Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Director/Board Member | |
Mckinsey Alumni Association | Director/Board Member | ||
Nederlandse Vereniging van Participatiemaatschappijen | Director/Board Member | ||
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Ipsen Bioinnovation Ltd.
Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
NEXSTIM PLC | Medical Specialties | Director/Board Member | |
Stichting Steun Emma Kinderziekenhuis | Investment Trusts/Mutual Funds | Chairman | |
BMEYE BV
BMEYE BV Electronic Equipment/InstrumentsElectronic Technology BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 21 |
Reino Unido | 17 |
Países Bajos | 7 |
China | 4 |
Francia | 2 |
Sectorial
Health Technology | 29 |
Commercial Services | 7 |
Finance | 5 |
Consumer Services | 4 |
Health Services | 3 |
Operativa
Director/Board Member | 178 |
Corporate Officer/Principal | 55 |
Independent Dir/Board Member | 19 |
Chief Executive Officer | 18 |
Chairman | 17 |
Las relaciones más conectadas
Insiders | |
---|---|
Pierre Legault | 45 |
Raphaël Wisniewski | 45 |
Barbara Dalton | 35 |
Chen-Ming Yu | 33 |
René Kuijten | 30 |
Michael Carter | 22 |
Jonathan Leslie Tobin | 19 |
Harry Finch | 15 |
Hamish Alan Cameron | 14 |
Nora Brennan | 13 |
Samantha Truex | 13 |
Michelle Doig | 12 |
Rajesh Chopra | 10 |
Andrew Muncey | 9 |
Niall M. B. Martin | 4 |
- Bolsa de valores
- Insiders
- Geoff Shapiro
- Conexiones Empresas